BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2788247)

  • 1. [3H]N-methylscopolamine binding to muscarinic receptors in human peripheral blood lymphocytes: characterization, localization on T-lymphocyte subsets and age-dependent changes.
    Eva C; Ferrero P; Rocca P; Funaro A; Bergamasco B; Ravizza L; Genazzani E
    Neuropharmacology; 1989 Jul; 28(7):719-26. PubMed ID: 2788247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
    el-Fakahany EE; Ramkumar V; Lai WS
    J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
    Norman AB; Eubanks JH; Creese I
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anomalous binding of [3H]N-methylscopolamine to rat brain muscarinic receptors.
    Lee JH; el-Fakahany EE
    Eur J Pharmacol; 1985 Apr; 110(2):263-6. PubMed ID: 3987816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    Lee JH; el-Fakahany EE
    J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of muscarinic receptors on rat pancreatic acini by using 125I-quinuclidinyl benzilate and N-[3H]-methylscopolamine].
    Aoki E; Adachi H; Noguchi M; Satoh S; Ohnishi S; Honda T; Konishi J
    Nihon Shokakibyo Gakkai Zasshi; 1991 Aug; 88(8):1571-8. PubMed ID: 1942611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of aging on the interaction of quinuclidinyl benzilate, N-methylscopolamine, pirenzepine, and gallamine with brain muscarinic receptors.
    Surichamorn W; Kim ON; Lee NH; Lai WS; el-Fakahany EE
    Neurochem Res; 1988 Dec; 13(12):1183-91. PubMed ID: 3237310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
    Tucek S; Musílková J; Nedoma J; Proska J; Shelkovnikov S; Vorlícek J
    Mol Pharmacol; 1990 Nov; 38(5):674-80. PubMed ID: 2233700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
    Lee NH; el-Fakahany EE
    J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of cholinergic muscarinic receptors in the rabbit iris.
    Honkanen RE; Abdel-Latif AA
    Biochem Pharmacol; 1988 Jul; 37(13):2575-83. PubMed ID: 3291881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic binding sites on bovine pulmonary arterial endothelial cells in culture.
    Aronstam RS; Ryan US; Catravas JD
    Pharmacology; 1992; 44(6):324-33. PubMed ID: 1508962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic antagonist binding to intact rat thymocytes.
    Maslinski W; Grabczewska E; Bartfai T; Ryzewski J
    Acta Chem Scand (Cph); 1990 Feb; 44(2):147-51. PubMed ID: 2206705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic receptor binding and muscarinic receptor-mediated inhibition of adenylate cyclase in rat brain myelin.
    Larocca JN; Ledeen RW; Dvorkin B; Makman MH
    J Neurosci; 1987 Dec; 7(12):3869-76. PubMed ID: 3694257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperativity manifest in the binding properties of purified cardiac muscarinic receptors.
    Wreggett KA; Wells JW
    J Biol Chem; 1995 Sep; 270(38):22488-99. PubMed ID: 7673239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of muscarinic cholinergic receptors in human SK-N-SH neuroblastoma cells by quaternary and tertiary ligands is dependent upon temperature, cell integrity, and the presence of agonists.
    Fisher SK
    Mol Pharmacol; 1988 Apr; 33(4):414-22. PubMed ID: 3357485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of cardiac muscarinic receptors recognized selectively by nonquaternary but not by quaternary ligands.
    Brown JH; Goldstein D
    J Pharmacol Exp Ther; 1986 Aug; 238(2):580-6. PubMed ID: 3016242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist-induced alteration in the membrane form of muscarinic cholinergic receptors.
    Harden TK; Petch LA; Traynelis SF; Waldo GL
    J Biol Chem; 1985 Oct; 260(24):13060-6. PubMed ID: 4055732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quaternary forms of classical muscarinic antagonists distinguish subpopulations of muscarinic receptors: correlation with gallamine-defined subpopulations.
    Ellis J; Lenox RH
    Biochem Biophys Res Commun; 1985 Feb; 126(3):1242-50. PubMed ID: 3977914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of 3H-N-methylscopolamine binding to intact rat thymocytes.
    Rinner I; Porta S; Schauenstein K
    Endocrinol Exp; 1990 Mar; 24(1-2):125-32. PubMed ID: 2361455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscarinic cholinergic receptors on intact human lymphocytes. Properties and subclass characterization.
    Bering B; Moises HW; Müller WE
    Biol Psychiatry; 1987 Dec; 22(12):1451-8. PubMed ID: 3676372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.